🔗 Permalink

Inventor profile of:

Kenya SHITARA

City:

Tokyo

Country:

Japan

Published Applications:

Last publication date:

2016-04-21

Top Assignees for applications by Kenya SHITARA

The entities that hold a legal rights for patent applications filed by inventor SHITARA Kenya:

KYOWA HAKKO KOGYO CO., LTD. 15 Tokyo, Japan
KYOWA HAKKO KIRIN CO., LTD. 13 Tokyo, Japan
Kyowa Hakko Kogyo Co., Ltd. 1 Chiyoda-ku, Tokyo, Japan
Masabumi SHIBUYA 1 Saitama, Japan
Japan as Represented by President of National Cancer Center 1 Tokyo, Japan
President National Cancer Center 1 TOKYO, Japan
TOKAI UNIVERSITY 1 Tokyo, Japan
Kyowa Medex Co., Ltd. 1 Tokyo, Japan

Recent patent applications by SHITARA Kenya

Kenya SHITARA from Tokyo, JP has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2016-04-21

US20160108136A1

Chemistry; metallurgy

Recombinant antibody composition

#2 | 2013-12-19

US20130337505A1

Chemistry; metallurgy

MONOCLONAL ANTIBODY CAPABLE OF BINDING TO HEPARIN-BINDING EPIDERMAL GROWTH FACTOR-LIKE GROWTH FACTOR

#3 | 2013-10-17

US20130273038A1

Chemistry; metallurgy

Human CDR-grafted antibody and antibody fragment thereof

#4 | 2012-11-01

US20120276090A1

Physics

Method for producing recombinant antibody and antibody fragment thereof

#5 | 2012-07-12

US20120177649A1

Human necessities

Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor

#6 | 2012-01-26

US20120022238A1

Chemistry; metallurgy

Effector function enhanced recombinant antibody composition

#7 | 2011-09-29

US20110236374A1

Chemistry; metallurgy

GENETICALLY RECOMBINANT ANTIBODY COMPOSITION CAPABLE OF BINDING SPECIFICALLY TO GANGLIOSIDE GM2

#8 | 2011-02-10

US20110034673A1

Chemistry; metallurgy

Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor

#9 | 2010-07-22

US20100184958A1

Human necessities

Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor

#10 | 2009-10-15

US20090258007A1

Physics

Anti-perp antibody

#11 | 2009-09-10

US20090226399A1

Chemistry; metallurgy

MEDICAMENTS COMPRISING GENE RECOMBINANT ANTIBODY AGAINST GANGLIOSIDE GD3

#12 | 2009-01-29

US20090028877A1

Chemistry; metallurgy

Antibody Composition Specifically Binding to Ganglioside Gm

#13 | 2009-01-01

US20090004186A1

Chemistry; metallurgy

Effector function enhanced recombinant antibody composition

#14 | 2008-10-02

US20080241884A1

Chemistry; metallurgy

Fused Protein Composition

#15 | 2008-09-04

US20080213266A1

Chemistry; metallurgy

Method for Treating CCR4-Related Diseases

#16 | 2008-07-29

US10204326

Methods using eosinophil-specific apoptosis inducer

#17 | 2008-07-10

US20080166345A1

Chemistry; metallurgy

MEDICAMENTS COMPRISING GENE RECOMBINANT ANTIBODY AGAINST GANGLIOSIDE GD3

#18 | 2008-04-24

US20080095765A1

Chemistry; metallurgy

IL-5R-specific antibody composition

#19 | 2007-06-28

US20070148165A1

Chemistry; metallurgy

Recombinant antibody composition

#20 | 2007-03-29

US20070073043A1

Chemistry; metallurgy

Process for producing humanized chimera antibody

#21 | 2006-11-23

US20060263362A1

Human necessities

Cancer metastasis inhibitor

#22 | 2006-10-26

US20060240015A1

Chemistry; metallurgy

Recombinant antibody against human insulin-like growth factor

#23 | 2006-05-16

US10166626

Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3

#24 | 2006-04-20

US20060084122A1

Chemistry; metallurgy

Method of judging leukemia, pre-leukemia or aleukemic malignant blood disease and diagnostic therefor

#25 | 2006-03-16

US20060058512A1

Chemistry; metallurgy

Process for producing humanized chimera antibody

#26 | 2006-03-16

US20060057139A1

Chemistry; metallurgy

Process for producing humanized chimera antibody

#27 | 2005-12-29

US20050287138A1

Chemistry; metallurgy

CCR4-specific antibody composition

#28 | 2005-11-15

US10265713

Process for producing humanized chimera antibody

#29 | 2005-10-13

US20050226867A1

Chemistry; metallurgy

IL-5R-specific antibody composition

#30 | 2005-02-10

US20050031613A1

Human necessities

Therapeutic agent for patients having human FcgammaRIIIa

#31 | 2005-01-06

US20050004003A1

Chemistry; metallurgy

Substance which inhibits binding of information transfer molecule for 1175-tyrosine phosphorylated KDR/Flk-1 and usages of the same

InventorID:

486202 ⎘